Key facts
- It has raised $245.0M across 1 recorded rounds; the latest was Early Stage VC (Series A) ($245.0M) in Oct 2023.
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Aiolos Bio
Create free account
No card required
Funding rounds
1 roundsOct 2023Early Stage VC (Series A)$245.0M▮
About Aiolos Bio
- Industry
- Drug Discovery
PA Mark — not yet priced
Aiolos Bio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Aiolos Bio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Aiolos Bio in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.